Host responses to infection

Infectious Diseases: Third Edition

Volumn 1, Issue , 2010, Pages 30-44

  Schooley, Robert ^a,c   Wilson, Cara ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896953913     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-04579-7.00002-2     Document Type: Chapter

References (141)

1. Abbas A.K., Lichtman A.H. Cellular and molecular immunology 2003, Saunders, Philadelphia. 5th ed.
2. Sethi S., Murphy T.F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008, 359:2355-2365.
3. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
4. Kuhns D.B., Priel D.A., Gallin J.I. Induction of human monocyte interleukin (IL)-8 by fibrinogen through the toll-like receptor pathway. Inflammation 2007, 30:178-188.
5. Osterloh A., Veit A., Gessner A., Fleischer B., Breloer M. Hsp60-mediated T cell stimulation is independent of TLR4 and IL-12. Int Immunol 2008, 20:433-443.
6. Akira S., Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004, 4:499-511.
7. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86:973-983.
8. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004, 430:257-263.
9. West A.P., Koblansky A.A., Ghosh S. Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol 2006, 22:409-437.
10. + T cells. J Immunol 2005, 175:1551-1557.
11. + T regulatory cells. J Immunol 2005, 175:8051-8059.
12. Gribar S.C., Anand R.J., Sodhi C.P., Hackam D.J. The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation. J Leukoc Biol 2008, 83:493-498.
13. Barton G.M. A calculated response: control of inflammation by the innate immune system. J Clin Invest 2008, 118:413-420.
14. Werts C., Tapping R.I., Mathison J.C., et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2001, 2:346-352.
15. Andersen-Nissen E., Smith K.D., Strobe K.L., et al. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci USA 2005, 102:9247-9252.
16. Gilleron M., Quesniaux V.F., Puzo G. Acylation state of the phosphatidylinositol hexamannosides from Mycobacterium bovis bacillus Calmette-Guérin and Mycobacterium tuberculosis H37Rv and its implication in Toll-like receptor response. J Biol Chem 2003, 278:29880-29889.
17. Thoma-Uszynski S., Stenger S., Takeuchi O., et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001, 291:1544-1547.
18. Netea M.G., Van der Graaf C., Van der Meer J.W., Kullberg B.J. Recognition of fungal pathogens by Toll-like receptors. Eur J Clin Microbiol Infect Dis 2004, 23:672-676.
19. Gazzinelli R.T., Ropert C., Campos M.A. Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites. Immunol Rev 2004, 201:9-25.
20. Heil F., Hemmi H., Hochrein H., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
21. Benito J.M. New insights into the mechanisms driving immune activation in HIV. AIDS Rev 2008, 10:254.
22. Mandl J.N., Barry A.P., Vanderford T.H., et al. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 2008, 14:1077-1087.
23. Meier A., Alter G., Frahm N., et al. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J Virol 2007, 81:8180-8191.
24. Krug A., Luker G.D., Barchet W., Leib D.A., Akira S., Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004, 103:1433-1437.
25. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
26. Edelmann K.H., Richardson-Burns S., Alexopoulou L., Tyler K.L., Flavell R.A., Oldstone M.B. Does Toll-like receptor 3 play a biological role in virus infections?. Virology 2004, 322:231-238.
27. Kurt-Jones E.A., Chan M., Zhou S., et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004, 101:1315-1320.
28. Parker L.C., Prince L.R., Sabroe I. Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity. Clin Exp Immunol 2007, 147:199-207.
29. Watts C., Zaru R., Prescott A.R., Wallin R.P., West M.A. Proximal effects of Toll-like receptor activation in dendritic cells. Curr Opin Immunol 2007, 19:73-78.
30. Fritz J.H., Ferrero R.L., Philpott D.J., Girardin S.E. Nod-like proteins in immunity, inflammation and disease. Nat Immunol 2006, 7:1250-1257.
31. Sirard J.C., Vignal C., Dessein R., Chamaillard M. Nod-like receptors: cytosolic watchdogs for immunity against pathogens. PLoS Pathog 2007, 3:e152.
32. Girardin S.E., Tournebize R., Mavris M., et al. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep 2001, 2:736-742.
33. Viala J., Chaput C., Boneca I.G., et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004, 5:1166-1174.
34. Ren T., Zamboni D.S., Roy C.R., Dietrich W.F., Vance R.E. Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity. PLoS Pathog 2006, 2:e18.
35. Park J.H., Kim Y.G., Shaw M., et al. Nod1/RICK and TLR signaling regulate chemokine and antimicrobial innate immune responses in mesothelial cells. J Immunol 2007, 179:514-521.
36. Diez E., Lee S.H., Gauthier S., et al. Birc1e is the gene within the Lgn1 locus associated with resistance to Legionella pneumophila. Nat Genet 2003, 33:55-60.
37. Willment J.A., Brown G.D. C-type lectin receptors in antifungal immunity. Trends Microbiol 2008, 16:27-32.
38. Brown G.D. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 2006, 6:33-43.
39. Tachado S.D., Zhang J., Zhu J., Patel N., Cushion M., Koziel H. Pneumocystis-mediated IL-8 release by macrophages requires coexpression of mannose receptors and TLR2. J Leukoc Biol 2007, 81:205-211.
40. Zhang J., Zhu J., Imrich A., et al. Pneumocystis activates human alveolar macrophage NF-kappaB signaling through mannose receptors. Infect Immun 2004, 72:3147-3160.
41. Le Cabec V., Emorine L.J., Toesca I., Cougoule C., Maridonneau-Parini I. The human macrophage mannose receptor is not a professional phagocytic receptor. J Leukoc Biol 2005, 77:934-943.
42. LeibundGut-Landmann S., Gross O., Robinson M.J., et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 2007, 8:630-638.
43. McGreal E.P., Rosas M., Brown G.D., et al. The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose. Glycobiology 2006, 16:422-430.
44. Sato K., Yang X.L., Yudate T., et al. Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor gamma chain to induce innate immune responses. J Biol Chem 2006, 281:38854-38866.
45. Gringhuis S.I., den Dunnen J., Litjens M., van Het Hof B., van Kooyk Y., Geijtenbeek T.B. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 2007, 26:605-616.
46. Hodges A., Sharrocks K., Edelmann M., et al. Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication. Nat Immunol 2007, 8:569-577.
47. Lai W.K., Sun P.J., Zhang J., et al. Expression of DC-SIGN and DC-SIGNR on human sinusoidal endothelium: a role for capturing hepatitis C virus particles. Am J Pathol 2006, 169:200-208.
48. Serrano-Gomez D., Dominguez-Soto A., Ancochea J., et al. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin mediates binding and internalization of Aspergillus fumigatus conidia by dendritic cells and macrophages. J Immunol 2004, 173:5635-5643.
49. Underhill D.M. Collaboration between the innate immune receptors dectin-1, TLRs, and Nods. Immunol Rev 2007, 219:75-87.
50. Herskovits A.A., Auerbuch V., Portnoy D.A. Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system. PLoS Pathog 2007, 3:e51.
51. Gantner B.N., Simmons R.M., Canavera S.J., Akira S., Underhill D.M. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 2003, 197:1107-1117.
52. Taylor P.R., Tsoni S.V., Willment J.A., et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol 2007, 8:31-38.
53. Underhill D.M., Rossnagle E., Lowell C.A., Simmons R.M. Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood 2005, 106:2543-2550.
54. Bekeredjian-Ding I., Roth S.I., Gilles S., et al. T cell-independent, TLR-induced IL-12p70 production in primary human monocytes. J Immunol 2006, 176:7438-7446.
55. Napolitani G., Rinaldi A., Bertoni F., Sallusto F., Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 2005, 6:769-776.
56. Roelofs M.F., Joosten L.A., Abdollahi-Roodsaz S., et al. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum 2005, 52:2313-2322.
57. Fritz J.H., Girardin S.E., Fitting C., et al. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur J Immunol 2005, 35:2459-2470.
58. Yoo N.J., Park W.S., Kim S.Y., et al. Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. Biochem Biophys Res Commun 2002, 299:652-658.
59. Aderem A. Phagocytosis and the inflammatory response. J Infect Dis 2003, 187(Suppl.2):S340-345.
60. Greenberg S., Grinstein S. Phagocytosis and innate immunity. Curr Opin Immunol 2002, 14:136-145.
61. Kantari C., Pederzoli-Ribeil M., Witko-Sarsat V. The role of neutrophils and monocytes in innate immunity. Contrib Microbiol 2008, 15:118-146.
62. Serbina N.V., Jia T., Hohl T.M., Pamer E.G. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 2008, 26:421-452.
63. Gordon S. Mononuclear phagocytes in immune defense. Immunology 2006, 181-201. Mosby, Toronto. 7th ed. D. Male, J. Brostoff, D.B. Roth, I. Roitt (Eds.).
64. Leon B., Lopez-Bravo M., Ardavin C. Monocyte-derived dendritic cells. Semin Hematol 2005, 17:313-318.
65. Tacke F., Randolph G.J. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 2006, 211:609-618.
66. Guillemin G.J., Brew B.J. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol 2004, 75:388-397.
67. Laskin D.L., Weinberger B., Laskin J.D. Functional heterogeneity in liver and lung macrophages. J Leukoc Biol 2001, 70:163-170.
68. Stout R.D., Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 2004, 76:509-513.
69. Kim M.K., Huang Z.Y., Hwang P.H., et al. Fc gamma receptor transmembrane domains: role in cell surface expression, gamma chain interaction, and phagocytosis. Blood 2003, 101:4479-4484.
70. Dale D.C., Boxer L., Liles W.C. The phagocytes: neutrophils and monocytes. Blood 2008, 112:935-945.
71. Bokoch G.M. Chemoattractant signaling and leukocyte activation. Blood 1996, 86:1649-1660.
72. Sabroe I., Dower S.K., Whyte M.K. The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis. Clin Infect Dis 2005, 41(Suppl.7):S421-426.
73. Bhatia M., Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004, 202:145-156.
74. Cohen J. The immunopathogenesis of sepsis. Nature 2002, 420:885-891.
75. Fang F.C. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2004, 2:820-832.
76. Nunoi H., Rotrosen D., Gallin J.I., Malech H.L. Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors. Science 1988, 242:1298-1301.
77. Quie P.G., White J.G., Holmes B., Good R.A. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest 1967, 46:668-679.
78. Mackey M.F., Barth R.J., Noelle R.J. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leukoc Biol 1998, 63:418-428.
79. Joosten S.A., Ottenhoff T.H. Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination. Hum Immunol 2008, 69:760-770.
80. Bettelli E., Korn T., Oukka M., Kuchroo V.K. Induction and effector functions of T(H)17 cells. Nature 2008, 453(7198):1051-1057.
81. Jankovic D., Liu Z., Gause W.C. Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol 2001, 22:450-457.
82. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2357.
83. Berenson L.S., Ota N., Murphy K.M. Issues in T-helper 1 development - resolved and unresolved. Immunol Rev 2004, 202:157-174.
84. Couper K.N., Blount D.G., Riley E.M. IL-10: the master regulator of immunity to infection. J Immunol 2008, 180:5771-5777.
85. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003, 278:1910-1914.
86. Langrish C.L., Chen Y., Blumenschein W.M., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
87. Yao Z., Painter S.L., Fanslow W.C., et al. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995, 155:5483-5486.
88. Kolls J.K., Linden A. Interleukin-17 family members and inflammation. Immunity 2004, 21:467-476.
89. Happel K.I., Dubin P.J., Zheng M., et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 2005, 202:761-769.
90. Huang W., Na L., Fidel P.L., Schwarzenberger P. Requirement of interleukin-17A for systemic anti- Candida albicans host defense in mice. J Infect Dis 2004, 190:624-631.
91. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007, 8:369-377.
92. Ye P., Rodriguez F.H., Kanaly S., et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001, 194:519-527.
93. Ghilardi N., Ouyang W. Targeting the development and effector functions of TH17 cells. Semin Immunol 2007, 19:383-393.
94. Maloy K.J. The interleukin-23/interleukin-17 axis in intestinal inflammation. J Intern Med 2008, 263:584-590.
95. Maloy K.J., Kullberg M.C. IL-23 and Th17 cytokines in intestinal homeostasis. Mucosal Immunol 2008, 1:339-349.
96. Kinugasa T., Sakaguchi T., Gu X., Reinecker H.C. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 2000, 118:1001-1011.
97. Liang S.C., Tan X.Y., Luxenberg D.P., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006, 203:2271-2279.
98. + T-cells: function and response to HIV infection. Curr HIV Res 2004, 2:23-37.
99. + T-cell memory. Nat Rev Immunol 2008, 8:107-119.
100. Prlic M., Williams M.A., Bevan M.J. Requirements for CD8 T-cell priming, memory generation and maintenance. Curr Opin Immunol 2007, 19:315-319.
101. Fuse S., Molloy M.J., Usherwood E.J. Immune responses against persistent viral infections: possible avenues for immunotherapeutic interventions. Crit Rev Immunol 2008, 28:159-183.
102. Klenerman P., Hill A. T cells and viral persistence: lessons from diverse infections. Nat Immunol 2005, 6:873-879.
103. Powers C., DeFilippis V., Malouli D., Fruh K. Cytomegalovirus immune evasion. Curr Top Microbiol Immunol 2008, 325:333-359.
104. + T cell immunity and viral escape following acute HIV-1 infection. J Immunol 2003, 171:3837-3846.
105. Cao J., McNevin J., McSweyn M., Liu Y., Mullins J.I., McElrath M.J. Novel cytotoxic T-lymphocyte escape mutation by a three-amino-acid insertion in the human immunodeficiency virus type 1 p6Pol and p6Gag late domain associated with drug resistance. J Virol 2008, 82:495-502.
106. Liu Y., McNevin J., Zhao H., et al. Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape. J Virol 2007, 81:12179-12188.
107. Keynan Y., Card C.M., McLaren P.J., Dawood M.R., Kasper K., Fowke K.R. The role of regulatory T cells in chronic and acute viral infections. Clin Infect Dis 2008, 46:1046-1052.
108. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat Rev Immunol 2008, 8:523-532.
109. + regulatory T cells. Nat Immunol 2003, 4:330-336.
110. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
111. Bennett C.L., Christie J., Ramsdell F., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001, 27:20-21.
112. Wildin R.S., Ramsdell F., Peake J., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001, 27:18-20.
113. + regulatory T cells specific for human papillomavirus antigens. Proc Natl Acad Sci USA 2007, 104:12087-12092.
114. Zammit D.J., Cauley L.S., Pham Q.M., Lefrancois L. Dendritic cells maximize the memory CD8 T cell response to infection. Immunity 2005, 22:561-570.
115. Steinman R.M., Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006, 311:17-58.
116. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004, 5:987-995.
117. Stokes C.R., Soothill J.F., Turner M.W. Immune exclusion is a function of IgA. Nature 1975, 255:745-746.
118. Kubo S.T., Nakayama T., Matsuoka K., Yonekawa H., Karasuyama H. Long term maintenance of IgE-mediated memory in mast cells in the absence of detectable serum IgE. J Immunol 2003, 170:775-780.
119. Hagan P., Blumenthal U.J., Dunn D., Simpson A.J.G., Wilkins H.A. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991, 349:243-245.
120. Slifka M.K., Ahmed R. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr Opin Immunol 1998, 10:252-258.
121. Kauppi-Korkeila M., van Alphen L., Madore D., et al. Mechanism of antibody-mediated reduction of nasopharyngeal colonization by Haemophilus influenzae type b studied in an infant rat model. J Infect Dis 1996, 174:1337-1340.
122. Mazanec M.B., Kaetzel C.S., Lamm M.E., et al. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci USA 1992, 89:6901-6905.
123. Oxelius V.A., Laurell A.B., Lindquist B., et al. IgG subclasses in selective IgA deficiency: importance of IgG2-IgA deficiency. N Engl J Med 1981, 304:1476-1477.
124. Zhang X.Q., Yang L., Ho D.D., Kuritzkes D.R., Chen I.S., Ching W.T., Chen Y.M., Schooley R.T. Human T-lymphotropic virus types I- and II-specific antibody-dependent cellular cytotoxicity: strain specificity and epitope mapping. J Infect Dis 1992, 165:805-812.
125. Gordon D.L., Hostetler M.K. Complement and host defense against microorganisms. Pathology 1986, 18:365-375.
126. Walport M.J. Complement [two parts]. N Engl J Med 2001, 344:1058-1066. 1140-4.
127. Schifferli J.A., Ng Y.C., Peters D.K. The role of complement and its receptor in the elimination of immune complexes. N Engl J Med 1986, 315:488-495.
128. Densen P. Complement. Principles and practice of infectious diseases 2005, Churchill Livingstone, Philadelphia. 6th ed. G.M. Mandell, R.G. Douglas, R. Dolin (Eds.).
129. Schumaker V.N., Zavodszky P., Poon R.H. Activation of the first component of complement. Annu Rev Immunol 1987, 5:21-42.
130. Wallis R. The lectin-pathway of complement activation: MBL, other collectins and ficolins. Immunobiology 2002, 204:433-445.
131. Fearon D.T., Austen K.F. The alternative pathway of complement: a system for host resistance to microbial infection. N Engl J Med 1980, 303:259-263.
132. Pangburn M.K., Rawat N. Structure and function of complement C5 convertase enzymes. Biochem Soc Trans 2002, 30:1006-1010.
133. Turner M.W. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996, 17:532-540.
134. Schwaeble W., Dahl M.R., Thiel S., et al. The mannan-binding lectin-associated serine proteases (MASPs) and Map19: four components of the lectin pathway activation complex encoded by two genes. Immunobiolgy 2002, 205:455-466.
135. Muller-Everhard H.J. The membrane attack complex of complement. Annu Rev Immunol 1986, 4:503-528.
136. Stanley K.K., Page M., Campbell A.K., et al. A mechanism for the insertion of complement component C9 into target membranes. Mol Immunol 1986, 23:451-458.
137. Nagata M., Hara T., Aoki T., et al. Inherited deficiency of ninth component of complement: an increased risk of meningococcal meningitis. J Pediatr 1989, 114:260-264.
138. Ross S.C., Rosenthal P.J., Berberich H.M., et al. Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals. J Infect Dis 1987, 155:1266-1275.
139. Sjoholm A.G., Kuijper E.J., Tijssen C.C., et al. Dysfunctional properdin in a Dutch family with meningococcal diseases. N Engl J Med 1988, 319:33-37.
140. Sullivan K.E., Petri M.A., Schmeckpeper B.J., et al. Prevalence of a mutation causing C2 deficiency in systemic lupus erythematosus. J Rheumatol 1994, 21:1128-1133.
141. Yamashina M., Ueda E., Kinoshita T., et al. Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1990, 323:1184-1189.